NLRP3 polymorphism is associated with protection against human T-lymphotropic virus 1 infection

AUTOR(ES)

Kamada, Anselmo Jiro, Pontillo, Alessandra, Guimarães, Rafael Lima, Loureiro, Paula, Crovella, Sergio, Brandão, Lucas André Cavalcanti

FONTE

Mem. Inst. Oswaldo Cruz

DATA DE PUBLICAÇÃO

2014-11

RESUMO

Inter-individual heterogeneity in the response to human T-lymphotropic virus 1 (HTLV-1) infection has been partially attributed to host genetic background. The antiviral activity of the inflammasome cytoplasmic complex recognises viral molecular patterns and regulates immune responses via the activation of interleukin (IL)-1 family (IL-1, IL-18 and IL-33) members. The association between polymorphisms in the inflammasome receptors NLRP1 and NLRP3 and HTLV-1 infection was evaluated in a northeastern Brazilian population (84 HTLV-1 carriers and 155 healthy controls). NLRP3 rs10754558 G/G was associated with protection against HTLV-1 infection (p = 0.012; odds ratio = 0.37). rs10754558 affects NLRP3 mRNA stability; therefore, our results suggest that higher NLRP3 expression may augment first-line defences, leading to the effective protection against HTLV-1 infection.

Documentos Relacionados

• Serologic confirmation of simian T-lymphotropic virus type I infection by using immunoassays developed for human T-lymphotropic virus antibody detection.
• HUMAN T-LYMPHOTROPIC VIRUS 1 (HTLV-1) AND HUMAN T-LYMPHOTROPIC VIRUS 2 (HTLV-2): GEOGRAPHICAL RESEARCH TRENDS AND COLLABORATION NETWORKS (1989-2012)
• Infection with the human T-lymphotropic virus type I. A review for clinicians.
• Examining Human T-Lymphotropic Virus Type 1 Infection and Replication by Cell-Free Infection with Recombinant Virus Vectors
• Infection of human endothelial cells by human T-lymphotropic virus type I.